Nisoldipine is available as an oral formulation as an extended-release tablet ( 20 mg, 30 mg, and 40 mg ) or as an extended-release hydrogel ( 8.5 mg, 17 mg, and 34 mg ). The patient should take the medication on an empty stomach or an hour after meals. The drug is to be swallowed whole with water and not crushed or divided.

**For Hypertension**

- In adults: Extended-release hydrogel is started at 17 mg by mouth daily, and the maximum daily dose is 34 mg by mouth daily.

- In the geriatric population: It is started at 8.5 mg orally each day.

**For Ischemic Heart Conditions**

- In adults: 8.5 to 34 mg of extended-release hydrogel formulation by mouth daily.

- In the geriatric population: 8.5 mg orally each day.

**Patients with Hepatic Impairment**

- 8.5 to 10 mg orally daily (do not exceed 30 mg daily)

**Patients with Renal Impairment**

- Because the pharmacokinetics of nisoldipine is not significantly different in patients with various degrees of renal impairment, dose adjustments areÂ not required in patients with mild to moderate renal impairment.

However, drug safety and efficacy in the pediatric population, pregnant women, and breastfeeding women remain unestablished.

The equivalency of Nisoldipine dose is as follows.